Romethan HCT Tablet 5/20/12.5 mg

Adult dose

This medication should be taken once daily, with one tablet taken with water, irrespective of meals. It is recommended to take it at the same time each day (e.g., morning) if possible. The maximum dosage is amlodipine/olmesartan medoxomil/hydrochlorothiazide of 10/40/25 mg. The recommended dosages are as follows: - 5/20/12.5 mg: Given to patients whose blood pressure is not adequately controlled with amlodipine/olmesartan medoxomil combined therapy.

Child dose

The safety and efficacy for pediatric patients under 18 years of age have not been established, so the administration of this medication is not recommended.

This medication can cause serious harm to the fetus and newborn during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used in patients with allergies to any components of this medication or similar drugs, pregnant or lactating women, patients with severe hypotension, or those with severe heart or kidney diseases. In patients with reduced blood volume or impaired kidney function, hypotension or worsening kidney function may occur, so careful evaluation of the patient's condition before administration and careful monitoring during treatment are required. Patients with severely impaired liver function, bile secretion disorders, or certain electrolyte imbalances should also be cautious when using this medication. As this medication lowers blood pressure, dizziness or lightheadedness may occur; caution should be exercised when performing high places work or driving. During treatment with this medication, electrolyte levels in the blood and kidney function should be regularly monitored to detect any abnormalities. There may be interactions with other drugs, so patients taking other medications should inform their healthcare provider. Use of this medication is not recommended during breastfeeding; if necessary, either breastfeeding should be discontinued or medication use should be stopped. The safety and efficacy in children under 18 years of age have not been established, so this medication is not recommended for this population. In case of overdose, symptoms such as hypotension and palpitations may occur, and appropriate treatment should be sought immediately.

Serious side effects

Urticaria, angioedema, Quincke's edema, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reaction, severe rash with high fever, blisters, skin peeling, mucosal pain in mouth/eyes, severe skin adverse reactions, difficulty breathing or shortness of breath, asthma attacks, respiratory disturbances accompanied by cough and fever, respiratory issues, jaundice (yellowing of skin or eyes), extreme fatigue, liver abnormalities

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory infection
• nasopharyngitis
• urinary tract infection
• salivary gland inflammation
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance

White and orange round film-coated tablets

Package unit

30 tablets/Alu-Alu[(10 tablets/Alu-Alu × 3)]